ctrl K

Watchlist Price Alert

Recursion Pharmaceuticals... (RXRX)

NASDAQ: RXRX · Real-Time Price · USD

4.57

0.32 (7.53%)

At close: May 16, 2025, 3:59 PM

4.38

-4.05%

Pre-market: May 19, 2025, 07:34 AM EDT

Recursion Pharmaceuticals Revenue Breakdown

Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Grant Revenue	351K	699K	162K	178K
Grant Revenue Growth	-49.79%	+331.48%	-8.99%	n/a
License and Service Revenue	58.49M	43.88M	39.68M	10M
License and Service Revenue Growth	+33.30%	+10.57%	+296.81%	n/a

Operating Expense Breakdown

Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Selling, General, and Administrative Revenue	54.65M	77.19M	37.76M	31.83M	31.41M	30.46M	29.2M	28.29M	22.87M	19.84M	19.49M	21.2M	21.07M	19.2M	15.69M	13.85M	8.94M	7.57M	6.96M	5.16M	5.56M
Selling, General, and Administrative Revenue Growth	-29.20%	+104.43%	+18.61%	+1.35%	+3.12%	+4.31%	+3.21%	+23.68%	+15.30%	+1.80%	-8.07%	+0.59%	+9.75%	+22.38%	+13.25%	+55.02%	+18.00%	+8.76%	+34.99%	-7.23%	n/a
Research and Development Revenue	129.63M	98.33M	74.6M	70.03M	64.16M	66.08M	70.01M	55.06M	46.68M	43.98M	40.84M	38.44M	32.44M	48.29M	33.25M	29.62M	24.11M	20.7M	16.54M	13.24M	12.84M
Research and Development Revenue Growth	+31.83%	+31.82%	+6.53%	+9.15%	-2.91%	-5.61%	+27.15%	+17.96%	+6.13%	+7.70%	+6.24%	+18.49%	-32.82%	+45.25%	+12.23%	+22.88%	+16.48%	+25.18%	+24.85%	+3.13%	n/a